Recor Medical (@ReCorMedical) / X
4.9 (581) · $ 12.00 · In stock
Clinical Results Highlights - Recor Medical
ReCor Medical Announces FDA Approval Of IDE For Pivotal Study Of Paradise® Ultrasound Denervation System For Treatment Of Hypertension - Cardiac Vascular News
Medical Design & Outsourcing on X: In this article, #RecorMedical CEO Lara Barghout details on leadership lessons and what she looks for when hiring. Lara also discusses how #medtech leaders can empower
ASPC on X: So much BREAKING NEWS in the week leading into #AHA23! Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension. @ReCorMedical #CVDPrevention @
Our Story - Recor Medical
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy
Recor Medical
Medical Product Outsourcing on X: Study: @ReCorMedical Paradise ultrasound renal denervation system helps reduce blood pressure
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
Recor Medical on X: REMINDER: Join our #ESC2023 symposium today
Recor Medical on X: We're excited to announce that ReCor's Paradise Ultrasound Renal Denervation System* demonstrated positive results in the RADIANCE-HTN TRIO study and has received Breakthrough Device designation from the U.S.
Neil Barman (@neilbarman) / X
Recor Medical - Ultrasound Renal Denervation
Recor Medical on X: Save the date – ReCor Medical Symposium at DGK 2021. “RDN with ultrasound in hypertension treatment” Thurs, April 8, 6-7:30 pm, Room 10. / X
